Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Medtronic plc.

Analysts are intrested in these 5 stocks: ( ($OXY) ), ( ($GTM) ), ( ($GEHC) ), ( ($IRD) ) and ( ($MDT) ). Here is a breakdown of their recent


Occidental, ZoomInfo, GEHC, Opus, Medtronic Trending by Analysts

Electrolux AB ( ($SE:ELUX.B) ) just unveiled an update. Electrolux Group has set the terms for a fully underwritten SEK 9.06 billion rights issue, ...

Electrolux launches fully underwritten SEK 9 billion rights issue to fund growth and strengthen balance sheet

In a report released today, David Roman from Goldman Sachs initiated coverage with a Hold rating on Medtronic and a price target of $84.00. Roman c...

Medtronic (MDT) Initiated with a Hold at Goldman Sachs

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medtronic (MDT) and Vyome Holdings (HIND) with bulli...

Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Vyome Holdings (HIND)

Piper Sandler Sticks to Their Hold Rating for Medtronic (MDT)

Medtronic ( ($MDT) ) has provided an update. On May 18, 2026, Medtronic plc announced a leadership transition in its Neuroscience Portfolio, with E...

Medtronic Announces Leadership Transition in Neuroscience Portfolio

Last week, stocks pulled back from record highs as oil, yields, and rate fears returned to the forefront. The S&P 500 (SPX) ended at 7,408.50, down...

The Week That Was, The Week Ahead: Macro and Markets, May 17

Alphabet ($GOOGL) is looking for ways to cut the cost of its next AI chip, as the race to build cheaper and faster AI systems heats up. Per a new


Alphabet’s (GOOGL) AI Chip Shake-Up Puts TSMC, Intel, and MediaTek in Focus

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Medtronic (MDT), Neogen (NEOG) and Community Healt...

Market Cap	$122.86B	P/E Ratio	14.02
52W High	$106.33	52W Low	$74.40
Div Yield	284.0%	Payout Ratio	78.8%
EPS Growth 3Y	-1.1%	52W Position	10.6%
Overall Score	52	Value Score	100
Quality Score	39	Technical Score	18

EPS Current Est	$5.55	EPS Next Est	$6.08
EPS Growth Est	+9.5%	DPS Growth 3Y	3.6%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MDT	$77.79	-1.03%	3.25M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MDT	$77.79	-1.0%	3.25M
3
4
5
6

MDT

MDT

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Medtronic plc. Data in Excel

Get Medtronic plc. Data in Excel